Down-regulating Glypican-3 Expression: Molecular-targeted Therapy for Hepatocellular Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|14|14|1183-1193

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.14, Iss.14, 2014-12, pp. : 1183-1193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoxia-inducible Factor-1alpha: Molecular-targeted Therapy for Hepatocellular Carcinoma

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-07 ,pp. : 1295-1304

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma

By  

Current Cancer Drug Targets, Vol. 16, Iss. 1, 2016-01 ,pp. : 53-70

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib

By Yau Thomas   Pang Roberta   Chan Pierre   Poon Ronnie T  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2187-2198

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targeted Therapy of Hepatocellular Carcinoma - Results of the First Clinical Studies

By  

Current Cancer Drug Targets, Vol. 11, Iss. 6, 2011-07 ,pp. : 714-733

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapies in Hepatocellular Carcinoma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-03 ,pp. : 966-974

Bentham Science Publishers

Access to resources Recommend Favorite